Search - tctmd.com

Displaying 1 - 9 of 9

Sort: Relevancy | Date

News Daily News

Tricuspid TEER Continues to Offer Benefits Through 3 Years: TRILUMINATE

Caitlin E. Cox

September 12, 2024

News Conference News NY Valves 2024

AV Block Common After Transcatheter Tricuspid Valve Replacement for TR

Michael O'Riordan

June 07, 2024

News Daily News

FDA Approves First Transcatheter Tricuspid Valve Replacement Device

L.A. McKeown

February 02, 2024

News Conference News TCT 2023

More TRILUMINATE Patients Flesh Out Tricuspid TEER’s Impact

Yael L. Maxwell

October 24, 2023

News Conference News EuroPCR 2022

TriCLASP: Tricuspid Repair With Pascal Safe, Effective at 30 days

Yael L. Maxwell

May 19, 2022

News Conference News TVT 2021

Pascal Device Works Well for Tricuspid Regurgitation in Commercial Market

Todd Neale

July 22, 2021

News Conference News TCT 2018

More Evidence That the MitraClip Might Be Useful in the Tricuspid Valve

Todd Neale

September 24, 2018

News Industry News

NaviGate Cardiac Structures Inc. (“NCSI”) reports world’s first successful transcatheter implantation of 52-mm tricuspid valve into a transplanted-heart patient to correct “torrential” tricuspid regurgitation (TR)

August 30, 2017

News Daily News

SCOUTing the ‘Forgotten Valve’: Promise for a New Percutaneous Treatment Option in Tricuspid Regurgitation

Yael L. Maxwell

April 04, 2017

Advertisement

Tricuspid TEER Continues to Offer Benefits Through 3 Years: TRILUMINATE

AV Block Common After Transcatheter Tricuspid Valve Replacement for TR

FDA Approves First Transcatheter Tricuspid Valve Replacement Device

More TRILUMINATE Patients Flesh Out Tricuspid TEER’s Impact

TriCLASP: Tricuspid Repair With Pascal Safe, Effective at 30 days

Pascal Device Works Well for Tricuspid Regurgitation in Commercial Market

More Evidence That the MitraClip Might Be Useful in the Tricuspid Valve

NaviGate Cardiac Structures Inc. (“NCSI”) reports world’s first successful transcatheter implantation of 52-mm tricuspid valve into a transplanted-heart patient to correct “torrential” tricuspid regurgitation (TR)

SCOUTing the ‘Forgotten Valve’: Promise for a New Percutaneous Treatment Option in Tricuspid Regurgitation

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content